Zionsville, IN, United States of America

Gary David Gustafson

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 7.0

ph-index = 7

Forward Citations = 187(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1993 - 1999)
  • Zionsville, IA (US) (2000)
  • Zionsville, IN (US) (2004 - 2021)

Company Filing History:


Years Active: 1993-2021

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: **The Innovative Contributions of Gary David Gustafson**

Introduction

Gary David Gustafson, based in Zionsville, Indiana, is a prolific inventor with an impressive portfolio of 20 patents. His work primarily focuses on the development of antifungal compounds and methods of their preparation, showcasing his commitment to advancing pharmaceutical science.

Latest Patents

Among Gustafson's notable inventions are several groundbreaking patents. One significant patent describes antifungal compounds represented by a specific formula, indicating their potential as inhibitors of metalloenzymes, including lanosterol demethylase (CYP51). Another recent patent details the synthesis of 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and related compounds, demonstrating his innovative approach to drug formulation through novel chemical processes.

Career Highlights

Gustafson has made significant contributions during his professional tenure at prominent companies such as Dow Agrosciences LLC and Viamet Pharmaceuticals, Inc. His roles at these organizations have been pivotal in advancing their research and development efforts, particularly in the fields of agriculture and therapeutics.

Collaborations

Throughout his career, Gustafson has collaborated with notable colleagues, including William Joel Hoekstra and Michael Thomas Sullenberger. These partnerships highlight the collaborative nature of innovation within the scientific community, enabling the development of advanced solutions in combating fungal infections.

Conclusion

With his extensive experience and innovative spirit, Gary David Gustafson continues to make significant contributions to the field of pharmaceuticals. His work on antifungal compounds not only enriches the scientific community but also offers promising avenues for future therapeutic advancements. The impact of his inventions is undeniable, solidifying his status as a key figure in contemporary scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…